Use of Clopidogrel, Prasugrel, or Ticagrelor and Patient Outcome after Acute Coronary Syndrome in Austria from 2015 to 2017

Background: Dual antiplatelet therapy improves patient outcome after acute coronary syndrome (ACS), but prescription differences of P2Y12 inhibitor treatments exist. The aim of the present investigation was to study the long-term utilization and patient outcomes of clopidogrel, prasugrel, and ticagr...

Descripción completa

Detalles Bibliográficos
Autores principales: Rezaei, Safoura Sheikh, Gleiss, Andreas, Reichardt, Berthold, Wolzt, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690682/
https://www.ncbi.nlm.nih.gov/pubmed/33114045
http://dx.doi.org/10.3390/jcm9113398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690682/
https://www.ncbi.nlm.nih.gov/pubmed/33114045
http://dx.doi.org/10.3390/jcm9113398

Ejemplares similares